0000899243-23-001632.txt : 20230111
0000899243-23-001632.hdr.sgml : 20230111
20230111195136
ACCESSION NUMBER: 0000899243-23-001632
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230110
FILED AS OF DATE: 20230111
DATE AS OF CHANGE: 20230111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamy Patrick
CENTRAL INDEX KEY: 0001961273
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 23524649
MAIL ADDRESS:
STREET 1: AKERO THERAPEUTICS, INC.
STREET 2: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-10
0
0001744659
Akero Therapeutics, Inc.
AKRO
0001961273
Lamy Patrick
C/O AKERO THERAPEUTICS, INC.,
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
See Remarks
Stock Option (Right to Buy)
44.37
2023-01-10
4
A
0
100000
0.00
D
2033-01-09
Common Stock
100000
100000
D
This option shall vest and become exercisable in forty-eight (48) equal monthly installments, commencing on January 10, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Senior Vice President, Commercial Strategy
/s/ Jonathan Young, attorney-in-fact
2023-01-11